A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

As GLP-1 users lose weight, they’ll likely be shopping for clothes in new sizes, translating into up to $13 billion a year in ...

Novo Nordisk A/S is seeking to broaden access to obesity treatments in Japan by targeting patients willing to pay ...

Scientists discovered GLP-1 mimics like Ozempic by way of the Gila monster, and now, a metabolite in python blood is also ...

By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as ...

A GLP-1-specific menu was created in Washington, D.C., after the co-founder was told about how hard it was to order at ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

How the rush to release affordable and accessible versions of weight loss drugs could reshape the fight against ‘diabesity’ ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

When Alyssa Cantrell began planning her wedding last year, she wanted two things: a sharp jawline and a tiny waist.